The Cycling News forum is still looking to add volunteer moderators with. If you're interested in helping keep our discussions on track, send a direct message to
In the meanwhile, please use the Report option if you see a post that doesn't fit within the forum rules.
Thanks!
Consequently, despite improvements to the science underlying the ABP, it is still possible for riders to micro-dose using EPO without getting caught. The Commission also heard that riders are confident that they can take a micro-dose of EPO in the evening because it will not show up by the time the doping control officers (“DCO” or “DCOs”) could arrive to test at 6am.
Limitations of the ABP
• Not all NADOs include test results into ADAMS, sharing of data is difficult. Some athletes have several passports.
• Whereabouts not centralized in ADAMS (e.g. USADA uses SIMON)
• Limits of ADAMS: Form an operational point of view, the software is complicated. SIMON, another system used by organizations, is better designed for managing the activities of the athletes (whereabouts).
• From now on: ABP software is only available with using Adams. So now NADOS are obliged to use ADAMS if they want to use the ABP software. This approach is criticized by NADOs.
• Manpower and capacity: the more data collected, the more documentation exists, the more complex it gets
• Still at the very beginning what interpretations of the profiles is concerned.
• Scientific uncertainty, various interpretations between experts, need of future assessment and scientific development.
• Access to calendar of the athlete needed
• Depending country laws and regulations (e.g. for blood collection, sample transport and data protection)
• An athlete can have two whereabouts failures before being sanctioned for the third
• Testing is not conducted b/w 23:00h and 6:00h so micro-dosing is possible during the night
• Possibility to hemodilute when not coming directly to the doping control after being notified for a PC testing
• An athlete could cheat by constantly using micro doses of EPO, by monitoring the values in ADAMS (knowing that they are just on their limits)
• Transparency of results in ADAMS - a delay of the release to athletes is favored
• Guidelines for PC-Testing do not exist
Do you know who Ashenden is?rhodescl said:The Hitch said:rhodescl said:IndianCyclist said:I think several athletes/teams have already conducted their own research on this and are already masters of microdosing
That's why it would be great if this were an actual scientific study which showed that a given amount of microdosing was undetectable AND produced measurable and significant performance enhancement. The scientific method to demonstrate such things is very well known. The fact that it was seemingly not followed in this case can only mean that the "study" was done with a different purpose in mind.
Thing is though, the fact that microdosing is undetectable and provides a benefit, is already well known. We already know that.
We know because Michael Ashenden said so.
Now that sounds very scientific indeed. An opinion poll of one person is even more convincing than testing of 8 which is, in turn, more convincing than testing 4-6 with 2-4 set aside as a double-blind control group.
Big Doopie said:Less than 3% improvement in performance in a month. So, one needs much better methods if one wants to transform from an average rider to a GT-contender overnight (or in a couple of weeks).
I don't think so. 3% at this level is absolutely huge.
Please don't mix Ashenden with Di Luca.Benotti69 said:We know because Ashenden, Frei, Ricco, Di Luca and a host of others informed us.
He does, but he pushes the agenda that the broadcast was pushing an agenda.SeriousSam said:rhodescl makes a fair point.
The Hitch said:Do you know who Ashenden is?rhodescl said:The Hitch said:rhodescl said:IndianCyclist said:I think several athletes/teams have already conducted their own research on this and are already masters of microdosing
That's why it would be great if this were an actual scientific study which showed that a given amount of microdosing was undetectable AND produced measurable and significant performance enhancement. The scientific method to demonstrate such things is very well known. The fact that it was seemingly not followed in this case can only mean that the "study" was done with a different purpose in mind.
Thing is though, the fact that microdosing is undetectable and provides a benefit, is already well known. We already know that.
We know because Michael Ashenden said so.
Now that sounds very scientific indeed. An opinion poll of one person is even more convincing than testing of 8 which is, in turn, more convincing than testing 4-6 with 2-4 set aside as a double-blind control group.
harryh said:neineinei said:Analysis of the blood profiles of the eight athletes who took part in the experiment demonstrated that they would not have fallen foul of the biological passport’s parameters. As France 2’s report concluded, the experiment demonstrates that “a clean passport is not necessarily the passport of a clean athlete.”
http://www.cyclingnews.com/news/french-television-report-shows-how-micro-dosing-can-beat-uci-biological-passport
Less than 3% improvement in performance in a month. So, one needs much better methods if one wants to transform from an average rider to a GT-contender overnight (or in a couple of weeks).
inrng focusing on the messenger and trivializing the message.TailWindHome said:http://inrng.com/2015/05/stade-2-bio-passport-old-news/
sniper said:don't know what harryh is saying.
In the VO2 max test, an average improvement of 6.1% was recorded.
harryh said:sniper said:don't know what harryh is saying.
In the VO2 max test, an average improvement of 6.1% was recorded.
while an average gain of 2.1% was reported in the 14km static bike time trial. In the 3,000-metres run, there was an average improvement of 2.8%.
Altitude training causes haematological fluctuations with relevance for the AthleteBiological Passport
*The impact of altitude training on haematological parameters and the Athlete Biological Passport (ABP) was evaluated ininternational-level elite athletes. One group of swimmers lived high and trained high (LHTH, n = 10) for three to four weeks at2130 m or higher whereas a control group (n = 10) completed a three-week training camp at sea-level. Haematological parameterswere determined weekly three times before and four times after the training camps. ABP thresholds for haemoglobin concentra-tion ([Hb]), reticulocyte percentage (RET%), OFF score and the abnormal blood profile score (ABPS) were calculated using theBayesian model. After altitude training, six swimmers exceeded the 99% ABP thresholds: two swimmers exceeded the OFF scorethresholds at day +7; one swimmer exceeded the OFF score threshold at day +28; one swimmer exceeded the threshold for RET%at day +14; and one swimmer surpassed the ABPS threshold at day +14. In the control group, no values exceeded the individualABP reference range. In conclusion, LHTH induces haematological changes in Olympic-level elite athletes which can exceed theindividually generated references in the ABP. Training at altitude should be considered a confounding factor for ABP interpreta-tion for up to four weeks after altitude exposure but does not consistently cause abnormal values in the ABP. Copyright © 2014John Wiley & Sons, Ltd.
Acute hyperhydration reduces athlete biological passport OFF-hr score
Anecdotal evidence suggests that athletes hyperhydrate to mask prohibited substances in urine and potentially counteract suspicious fluctuations in blood parameters in the athlete biological passport (ABP). It is examined if acute hyperhydration changes parameters included in the ABP. Twenty subjects received recombinant human erythropoietin (rhEPO) for 3 weeks. After 10 days of rhEPO washout, 10 subjects ingested normal amount of water (∼ 270 mL), whereas the remaining 10 ingested a 1000 mL bolus of water. Blood variables were measured 20, 40, 60, and 80 min after ingestion. Three days later, the subjects were crossed-over with regard to water ingestion and the procedure was repeated. OFF-hr was reduced by ∼ 4%, ∼ 3%, and ∼ 2% at 40, 60, and 80 min, respectively, after drinking 1000 mL of water, compared with normal water ingestion (P < 0.05). Forty percent of the subjects were identified with atypical blood profiles (99% specificity level) before drinking 1000 mL of water, whereas 11% (n = 18), 10% and 11% (n = 18) were identified 40, 60, and 80 min, respectively, after ingestion. This was different (P < 0.05) compared with normal water intake, where 45% of the subjects were identified before ingestion, and 54% (n = 19), 45%, and 47% (n = 19) were identified 40, 60, and 80 min, respectively, after ingestion. In conclusion, acute hyperhydration reduces ABP OFF-hr and reduces ABP sensitivity.
Benotti69 said:Vaughters silence on this is deafening. But not unsurprising. When a team spends money (half a million) on internal testing it is not to ensure riders are not doping, but to ensure the 'program' is working and undetecable.
harryh said:Big Doopie said:Less than 3% improvement in performance in a month. So, one needs much better methods if one wants to transform from an average rider to a GT-contender overnight (or in a couple of weeks).
I don't think so. 3% at this level is absolutely huge.
An average rider with 360W@FTP can improve it to 371W. He's still far away from being a GT-contender. Of course it would be interesting to see a longer study.